REPL Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Replimune Group, Inc. Securities Class Action
Robbins LLP issued a reminder of the lead plaintiff deadline for a class action lawsuit against Replimune Group, Inc. The lawsuit alleges the company misled investors regarding the efficacy of its lead product candidate RP1, which the FDA rejected in April 2026, causing significant stock declines.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.